test

Jim Harding

@Propel Bio Management, Llc

Latest period2024 - Q3ReportedManaged Assets$172.411MTotal holdings21
Assets growth rate11.82%Assets growth rate (2-Q avg)0.79%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Propel Bio Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 21 positions.

Assets under management

The assets under management (AUM) of Propel Bio Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 172.411M in assets, with a quarterly growth rate of 11.82% and a 2-quarter average growth rate of 0.79%. The portfolio is managed by Jim Harding, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
APLTApplied Therapeutics Inc
Recent Activity
32.39%
$55.827M
6.568M shares@ $8.5 avg price
PAGPPlains Gp Holdings Lp-cl
Recent Activity
Decreased -7.28%
13.66%
$23.539M
1.272M shares@ $18.5 avg price
PHATPhathom Pharmaceuticals I
Recent Activity
9.13%
$15.728M
869,927 shares@ $18.08 avg price
ACHVAchieve Life Sciences Inc
Recent Activity
6.75%
$11.628M
2.453M shares@ $4.74 avg price
TCRXTscan Therapeutics Inc
Recent Activity
6.03%
$10.394M
2.087M shares@ $4.98 avg price
AKROAkero Therapeutics Inc
Recent Activity
Increased 4.88%
5.72%
$9.862M
343,729 shares@ $28.69 avg price
MDGLMadrigal Pharmaceuticals
Recent Activity
5.3%
$9.132M
43,032 shares@ $212.22 avg price
RNAAvidity Biosciences Inc
Recent Activity
4.76%
$8.199M
178,500 shares@ $45.93 avg price
ARDXArdelyx Inc
Recent Activity
Increased 15.84%
4.28%
$7.379M
1.071M shares@ $6.9 avg price
TSATTelesat Corp
Recent Activity
2.8%
$4.817M
365,781 shares@ $13.18 avg price